Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Texas Medical Center
Specialty
Cancer and Hematology, Adult Hematology-Oncology
Phone: 832-822-4208
Fax: 832-825-1503
Email
klmcclai@texaschildrens.org
Address
6701 Fannin St., Ste. 1510.11
Houston, TX 77030
Research Laboratory
Research Area
Kenneth L. McClain, MD, PhD
Director, Histiocytosis Program
Director, Pediatric Lymphoma-Histiocytosis Fellowship Program
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| University of Minnesota Medical School at Minneapolis | Fellowship | Hematology-Oncology | 1981 |
| National Institutes of Health | Fellowship | Molecular & Human Genetics | 1979 |
| Johns Hopkins University School of Medicine | Residency | Pediatrics | 1976 |
| Johns Hopkins University School of Medicine | Internship | Pediatrics | 1974 |
| University of Chicago, Pritzker School of Medicine | Medical School | Doctor of Medicine | 1973 |
| University of Chicago, Pritzker School of Medicine | University | Doctor of Philosophy | 1972 |
About
Dr. Kenneth McClain is Director of the Histiocytosis Program at Texas Children’s Cancer and Hematology Center and a member of the leukemia and lymphoma programs. Dr. McClain and Dr. Carl Allen see 150 newly-diagnosed patients with a variety of histiocytic diseases each year and follow more than 1,000 active patients, including patients from five continents.
His clinical interests include: hematologic disorders, leukemia, lymphoma, histiocytosis, and sickle cell disease.
Board Certifications
American Board of Pediatrics - Pediatrics
American Board of Pediatrics - Pediatric Hematology/Oncology
Organizations
| Organization Name | Role |
|---|---|
| American Society of Hematology (ASH) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Current Reviews in Pediatrics | Editorial Board, 2004-Present |
| Gulf Coast Hematology Society (GCHS) | Past-President |
| Histiocyte Society | Past-President |
| Histiocytosis Association of America (HAA) | Board Member |
| PDQ Pediatric Treatment Editorial Board | 2006 - Present |
| Society for Pediatric Research | Member, 1986-Present |
Research Statement
Dr. Kenneth McClain's research is focused on the clinical and biologic aspects of Langerhans cell histiocytosis (LCH). He is a key member of the clinical trials group of the Histiocyte Society. A number of clinical studies are in progress or development including new therapeutic interventions for CNS LCH. Current biologic studies in his lab are focused on determining the gene expression profiles Langerhans cells and lymphocytes from control and patient tissues and making clinical correlations.
Research Interests
Clinical and biologic aspects of Langerhans cell histiocytosis (LCH)
Gene expression profiles
Selected Publications
Awards & Honors
2019: George R. Buchanan Lectureship Award, American Society of Pediatric Hematology/Oncology
2009: Who's Who
2005-2009: Texas Super Doctor
2003-2009: Best Doctor
2007: Nesbit Prize for Best Clinical Paper. 23rd Annual Histiocyte Society Meeting, Cambridge England
2005-2006: Texas Super Doctor
2004: Montclair Who’s Who in Healthcare
2003-2008: Best Doctors in America
2002: Visiting Professor of Pediatrics. McGill University.
2002: Ph.D. Thesis Opponent. The Karolinska Institute, Stockholm Sweden
2000-2003: President, Histiocyte Society
2000: Who’s Who
1996: Visiting Professor of Pediatrics, Charles University, Second Medical Faculty, Motol, Prague, Czech Republic, Conferred
1998-2001: Editorial Board, Medical and Pediatric Oncology
AcademicKeys Who’s Who in Medical Sciences
Language
English
Latest Videos
Latest videos
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.